Matsushita Michiko, Iwasaki Takeshi, Nonaka Daisuke, Kuwamoto Satoshi, Nagata Keiko, Kato Masako, Kitamura Yukisato, Hayashi Kazuhiko
Department of Pathobiological Science and Technology, School of Health Science, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
†Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Yonago Acta Med. 2017 Sep 15;60(3):145-153. eCollection 2017 Sep.
Merkel cell carcinomas (MCCs), clinically aggressive neuroendocrine skin cancers, are divided into Merkel cell polyomavirus (MCPyV)-positive and -negative tumors, which show different clinicopathological features and may develop through different mechanisms of carcinogenesis. Aberrant expression of activation-induced cytidine deaminase (AID) as a genomic modulator was demonstrated through pathogen-related NF-κB signal in -associated gastric cancer, adult T cell leukemia/lymphoma (HTLV-1), hepatoma (HCV), and Burkitt lymphoma (EBV).
To elucidate the relation of aberrant AID expression in MCPyV-positive and -negative MCCs, we evaluated immunohistochemical expressions of AID and AID-regulating factors between 24 MCPyV-positive and 17 MCPyV-negative MCCs.
AID expression was significantly higher in MCPyV-negative MCCs than MCPyV-positive ones ( = 0.026), although expression of NF-κB p65 (phospho S536) (AID-enhancer) was significantly higher in MCPyV-positive MCCs than MCPyV-negative ones ( = 0.034). Expressions of PAX5 and c-Myb were not significantly different between these subgroups. Expressions of AID and AID-regulating factors were not correlated to prognosis of MCC patients.
Our findings suggest that although pathogen-induced AID expression through upregulation of NF-κB may be relevant to carcinogenesis of MCPyV-positive MCCs, the significantly higher aberrant AID expression in MCPyV-negative MCCs is consistent with the fact that MCPyV-negative MCCs have an extremely higher mutation burden than MCPyV-positive ones.
默克尔细胞癌(MCCs)是临床上具有侵袭性的神经内分泌皮肤癌,分为默克尔细胞多瘤病毒(MCPyV)阳性和阴性肿瘤,它们表现出不同的临床病理特征,可能通过不同的致癌机制发展而来。激活诱导的胞苷脱氨酶(AID)作为一种基因组调节剂的异常表达已在与病原体相关的NF-κB信号相关的胃癌、成人T细胞白血病/淋巴瘤(HTLV-1)、肝癌(HCV)和伯基特淋巴瘤(EBV)中得到证实。
为了阐明MCPyV阳性和阴性MCCs中AID异常表达的关系,我们评估了24例MCPyV阳性和17例MCPyV阴性MCCs之间AID和AID调节因子的免疫组化表达。
MCPyV阴性MCCs中AID表达显著高于MCPyV阳性MCCs(P = 0.026),尽管MCPyV阳性MCCs中NF-κB p65(磷酸化S536)(AID增强子)的表达显著高于MCPyV阴性MCCs(P = 0.034)。这些亚组之间PAX5和c-Myb的表达没有显著差异。AID和AID调节因子的表达与MCC患者的预后无关。
我们的研究结果表明,尽管通过NF-κB上调由病原体诱导的AID表达可能与MCPyV阳性MCCs的致癌作用有关,但MCPyV阴性MCCs中异常AID表达显著更高,这与MCPyV阴性MCCs比MCPyV阳性MCCs具有极高的突变负担这一事实相一致。